The Current Ratio as of December 2024 (TTM) for iCAD, Inc. (ICAD) is 4.02

According to iCAD, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.02. This represents a change of -7.47% compared to the average of 4.34 of the last 4 quarters.

iCAD, Inc. (ICAD) Historical Current Ratio (quarterly & annually)

How has ICAD Current Ratio performed in the past?

The mean historical Current Ratio of iCAD, Inc. over the last ten years is 2.36. The current 4.02 Current Ratio has changed 16.96% with respect to the historical average. Over the past ten years (40 quarters), ICAD's Current Ratio was at its highest in in the March 2024 quarter at 4.71. The Current Ratio was at its lowest in in the September 2018 quarter at 1.39.

iCAD, Inc. (ICAD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of iCAD, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

iCAD, Inc. (ICAD) Average Current Ratio

How has ICAD Current Ratio performed in the past?

The current Current Ratio of iCAD, Inc. (ICAD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

iCAD, Inc. (ICAD) Current Ratio vs. Peers

How is ICAD’s Current Ratio compared to its peers?

iCAD, Inc.’s Current Ratio is less than Profound Medical Corp. (6.12), less than SI-BONE, Inc. (8.25), less than Sight Sciences, Inc. (10.18), less than Nevro Corp. (5.02), greater than Paragon 28, Inc. (3.50), greater than STRATA Skin Sciences, Inc. (1.13), greater than Sientra, Inc. (0.57), greater than AxoGen, Inc. (3.74), greater than Ainos, Inc. (1.37), greater than LENSAR, Inc. (3.37), greater than Aziyo Biologics, Inc. (0.94), less than INVO Bioscience, Inc. (0), less than enVVeno Medical Corporation (22.01), greater than Establishment Labs Holdings Inc. (3.62), less than CVRx, Inc. (11.32), greater than Surgalign Holdings, Inc. (2.68), greater than Surmodics, Inc. (3.96), greater than Biomerica, Inc. (3.00), greater than Movano Inc. (3.31),

Build a custom stock screener for iCAD, Inc. (ICAD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iCAD, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

iCAD, Inc. (ICAD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like iCAD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.